Akebia Therapeutics, Inc. (AKBA): Price and Financial Metrics
AKBA Price/Volume Stats
| Current price | $2.07 | 52-week high | $2.48 |
| Prev. close | $1.93 | 52-week low | $0.80 |
| Day low | $1.92 | Volume | 6,520,000 |
| Day high | $2.09 | Avg. volume | 2,499,464 |
| 50-day MA | $1.91 | Dividend yield | N/A |
| 200-day MA | $1.46 | Market Cap | 451.63M |
AKBA Stock Price Chart Interactive Chart >
Akebia Therapeutics, Inc. (AKBA) Company Bio
Akebia Therapeutics focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. The company was founded in 2007 and is based in Cambridge, Massachusetts.
AKBA Price Returns
| 1-mo | 13.11% |
| 3-mo | 30.19% |
| 6-mo | 39.86% |
| 1-year | 48.92% |
| 3-year | 3.50% |
| 5-year | -75.85% |
| YTD | 8.95% |
| 2024 | 53.23% |
| 2023 | 114.90% |
| 2022 | -74.47% |
| 2021 | -19.29% |
| 2020 | -55.70% |
Continue Researching AKBA
Here are a few links from around the web to help you further your research on Akebia Therapeutics Inc's stock as an investment opportunity:Akebia Therapeutics Inc (AKBA) Stock Price | Nasdaq
Akebia Therapeutics Inc (AKBA) Stock Quote, History and News - Yahoo Finance
Akebia Therapeutics Inc (AKBA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...